Assignee
ARISAN THERAPEUTICS INC
US·4 granted patents·3 pending applications·2 citations·filing 2017–2023
Top patents by PatentIndex Score
7 records- 0176US11352328B2Heterocyclic compounds for the treatment of arenavirusARISAN THERAPEUTICS INC·Filed 2017·Granted Jun 7, 2022·2 cites·29 claims
- 0264US2022281825A1Heterocyclic compounds for the treatment of arenavirus infectionARISAN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0358US2023303569A1Heterocyclic compounds as therapeutic agentsARISAN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0451US12419865B2Compounds for the treatment of arenavirus infectionARISAN THERAPEUTICS INC·Filed 2019·Granted Sep 23, 2025·0 cites·19 claims
- 0550US2024238265A1Adamantane amides and thioamides for the treatment of ebolavirus infectionARISAN THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0644US12240857B2Adamantane derivatives for the treatment of filovirus infectionARISAN THERAPEUTICS INC·Filed 2018·Granted Mar 4, 2025·0 cites·20 claims
- 0737US11548893B2Enantiomerically pure adamantane carboxamides for the treatment of filovirus infectionARISAN THERAPEUTICS INC·Filed 2018·Granted Jan 10, 2023·0 cites·52 claims
Join the waitlist — get patent alerts
Get an alert when ARISAN THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →